Title
Category
Credits
Event date
Cost
  • Alzheimer’s Disease
  • Cognitive Impairment
  • Pharmacology
  • 0.48 AANP Contact Hours
  • 0.48 AANP Pharmacology Contact Hours
  • 0.50 AMA PRA Category 1 Credit
$0.00
Embark on a captivating journey with our distinguished neurology faculty as they delve into the revolutionary world of FDA-approved monoclonal antibody therapies targeting β-amyloid in the treatment of Alzheimer disease (AD). Uncover clinical efficacy, safety nuances, and differences between these newer disease-modifying agents compared to older medications used for AD.
  • Alzheimer’s Disease
  • Cognitive Impairment
  • Pharmacology
  • 1.00 AANP Contact Hours
  • 0.33 AANP Pharmacology Contact Hours
  • 1.00 AMA PRA Category 1 Credit
$0.00
Catching Alzheimer disease early is critical, yet studies show that 40% of cases may be missed. Join this session to hear a candid discussion between a primary care physician and a geriatric neurologist about how to identify patients with Alzheimer disease and how new and emerging therapies may benefit these patients. 
  • Opioid Use Disorder (OUD)
  • Prescribing: Opioid(s)
  • Pharmacology
  • 0.77 AANP Contact Hours
  • 0.77 AANP Pharmacology Contact Hours
  • 0.75 AMA PRA Category 1 Credit
$0.00
Immerse yourself in a case-based exploration of the complex landscape surrounding opioids and opioid use disorder. In this podcast, you will explore guideline recommendations for safe opioid prescribing, gain insights into diagnosing opioid use disorder, and understand the essential indications for buprenorphine in OUD. Acquire practical knowledge to navigate pain management challenges amidst the opioid epidemic, fostering responsible practices in patient care.
  • Prescribing: Opioid(s)
  • Pharmacology
  • 3.00 AMA PRA Category 1 Credit
  • 3.00 ANCC
$21.00
Opioid analgesic medications can bring substantial relief to patients suffering from pain. However, the inappropriate use, abuse, and diversion of prescription drugs in America, particularly prescription opioids, has increased dramatically in recent years and has been identified as a national public health epidemic. A set of clinical tools, guidelines, and recommendations are now available for prescribers who treat pain patients with opioids.
  • Drug Diversion
  • Pharmacology
  • 3.00 ANCC
$30.00
MANDATORY WEST VIRGINIA NURSING CEU. Fulfills the WV Board of Nursing requirement of 3 contact hours of continuing education on drug diversion and responsible prescribing of controlled substances. Per Chapter 30-1-7a, each nurse must complete 3 contact hours initially and then 1 contact hour, thereafter, annually of CE for drug diversion training, best-practice prescribing of controlled substances training and training on prescribing and administration of an opioid antagonist if they prescribe, administer or dispense controlled substances.
  • Pharmacology
  • 0.70 AANP Contact Hours
  • 0.70 AANP Pharmacology Contact Hours
  • 0.75 AMA PRA Category 1 Credit
$0.00
Enhance your knowledge of COVID-19 management for non-hospitalized patients with this comprehensive Q&A. Expert faculty have answered important questions on guideline recommendations for pharmacologic treatments and provided essential insights for navigating potential drug-drug interactions. Add this direct and practical resource to your clinical toolbox and feel equipped to treat COVID-19 in the outpatient setting. 
  • Pharmacology
  • Pain Management
  • 3.50 AANP Contact Hours
  • 1.59 AANP Pharmacology Contact Hours
  • 3.50 AMA PRA Category 1 Credit
$0.00
The nation is facing competing public health issues: the need to treat a large number of Americans with acute and chronic pain vs the crisis of prescription opioid abuse. Pri-Med’s P.A.C.T.: Practical Approaches to Comprehensive Treatment of Pain curriculum focuses on improving practitioners’ ability to recognize, diagnose, and classify pain; educating clinicians on the full spectrum of pain management options, including non-opioid pharmacologic interventions; and providing risk reduction strategies through integration of opioids into individualized pain management plans.
  • Pharmacology
  • Gender-affirming Care
  • LGBTQ
  • 1.00 AANP Contact Hours
  • 1.00 AANP Pharmacology Contact Hours
  • 1.00 AMA PRA Category 1 Credit
$0.00
This engaging session explores primary care for gender-diverse individuals. Through practical case studies, clinicians will navigate gender-affirming hormone therapies (GAHTs), including the benefits, complications, and comprehensive care strategies for patients. Enhance your expertise in supporting diverse patient populations.
  • Pain Management
  • Pharmacology
  • 0.50 AANP Contact Hours
  • 0.25 AANP Pharmacology Contact Hours
  • 0.50 AMA PRA Category 1 Credit
$0.00
Clinicians who manage patients with painful conditions have many practical questions regarding the various treatment modalities—ranging from nonpharmacologic options to non-opioid therapies and opioid prescribing; they also seek information on the identification of risk for opioid use disorder (OUD) along with the management and referral of patients with OUD. In this activity, Dr. Katherine Galluzzi addresses many questions that participants in Pri-Med CE/CME activities on pain management have asked, providing practical and actionable answers.
  • Pharmacology
  • 1.00 AANP Contact Hours
  • 1.00 AANP Pharmacology Contact Hours
  • 1.00 AMA PRA Category 1 Credit
$0.00
In this interactive and clinically focused presentation, we will delve into the challenges clinicians encounter when prescribing antibiotics, with a strong emphasis on the appropriate use of antibiotics for common outpatient indications. We will explore the integration of newly approved oral antibiotic agents, discuss the efficacy of oral vs intravenous antibiotics, and examine the appropriate duration of antibiotic therapy.

Pages